Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Regulatory Trackers
Agency Leadership
Compliance
Complete Response Letters
Drug Review Profiles
Scrip
US FDA: Recall Of BD Alaris Infusion Pump Is High-Risk Class I
Apr 16 2021
•
By
Shawn M. Schmitt
BD Alaris Infusion Pump Model 8100 • Source: BD
More from Recalls
More from Policy & Regulation